Vistagen Therapeutics Inc

General ticker "VTGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $78.6M

Vistagen Therapeutics Inc does not follow the US Stock Market performance with the rate: -34.4%.

Estimated limits based on current volatility of 3.9%: low 2.33$, high 2.52$

Factors to consider:

  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

  • 2024-03-31 to 2025-03-31 estimated range: [2.70$, 8.63$]
  • 2025-03-31 to 2026-03-31 estimated range: [1.55$, 5.33$]

Financial Metrics affecting the VTGN estimates:

  • Negative: Non-GAAP EPS, $ of -2.07 <= 0.10
  • Negative: Operating profit margin, % of -96.88 <= 1.03
  • Negative: Operating cash flow per share per price, % of -23.08 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -24.50 <= 3.85

Similar symbols

Short-term VTGN quotes

Long-term VTGN plot with estimates

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue $1.11MM $0.00MM $1.06MM
Operating Expenses $48.89MM $59.27MM $34.09MM
Operating Income $-47.78MM $-59.27MM $-33.02MM
Non-Operating Income $0.02MM $0.03MM $3.66MM
Interest Expense $0.00MM $0.02MM $0.00MM
R&D Expense $35.41MM $44.38MM $20.02MM
Income(Loss) $-47.76MM $-59.24MM $-29.36MM
Taxes $0.00MM $0.01MM $0.00MM
Profit(Loss) $-47.76MM $-59.25MM $-29.36MM
Stockholders Equity $64.72MM $12.08MM $114.29MM
Inventory $2.45MM $0.74MM $0.00MM
Assets $74.64MM $21.09MM $123.65MM
Operating Cash Flow $-45.26MM $-49.72MM $-25.81MM
Capital expenditure $0.20MM $0.21MM $0.06MM
Investing Cash Flow $-0.20MM $-0.74MM $-0.06MM
Financing Cash Flow $10.48MM $-1.04MM $128.40MM
Earnings Per Share* $-7.24 $-8.51 $-1.52

* EPS are Split Adjusted, recent splits may be reflected with a delay.